The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of preoperative chemotherapy and chemoradiation for localized gastric and gastroesophageal junction adenocarcinoma (LGCA).
Elena Elimova
No relevant relationships to disclose
Roopma Wadhwa
No relevant relationships to disclose
Kazuki Sudo
No relevant relationships to disclose
Hironori Shiozaki
No relevant relationships to disclose
Rebecca Slack
No relevant relationships to disclose
Hsiang-Chun Chen
No relevant relationships to disclose
Brian D. Badgwell
No relevant relationships to disclose
Aurelio Matamoros
No relevant relationships to disclose
Jeffrey H. Lee
No relevant relationships to disclose
Brian Weston
No relevant relationships to disclose
Manoop S. Bhutani
No relevant relationships to disclose
Mariela A. Blum
No relevant relationships to disclose
Jeannelyn Estrella
No relevant relationships to disclose
Prajnan Das
Research Funding - Genentech
Jaffer A. Ajani
Research Funding - Sanofi